CONGJING radiofrequency moxibustion therapy of class II came!

On November 25, 2022, after going through the process of product design and development, clinical effectiveness verification, registration testing, system assessment, review and approval, etc., CONGJING Group successfully obtained the second class medical device registration certificate with its RF moxibustion ultra-short wave therapy instrument CJ360-I/II!

As of November 2022, only 17 types of ultra-short wave products (approved in the form of domestic medical devices) have been approved for medical device registration certificate in China. It is of great significance that CONGJING Group's first ultra-short wave therapeutic instrument (moxibustion chamber), which is based on the inheritance and innovation of traditional Chinese moxibustion therapy theory and the integration of Chinese traditional medicine and engineering, has been approved for Class II medical device certificate.

The audit process for Class II medical devices is very strict. First of all, in order to ensure the safety of people's lives, the state controls the safety and effectiveness of medical devices. At the same time, the recognition of the qualification must meet the requirements of complete research and development process, sufficient production capacity, sound quality management system and complete talent echelon. Therefore, for medical device companies, the identification of the registration certificate represents the strong strength of the company.